XVIVO Heart Assist Transport System: Direct procurement of donor hearts from DCD donation
Study summary
The purpose of the clinical investigation is to support the use of direct procurement of donor hearts in donation after circulatory death followed by hypothermic oxygenated perfusion using the XVIVO Heart Assist Transport System. Thereby increasing the utilization of DCD donor hearts in donation after circulatory death.
The primary objective is to evaluate patient survival after direct procurement and hypothermic oxygenated machine perfusion of DCD donor hearts using the XVIVO Heart Assist Transport System.
The secondary objectives are to evaluate patient outcomes and graft function post-transplant.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Recipient Criteria:
1. Age ≥18 years
2. Signed informed consent form
3. Accepted and/or listed for heart transplantation
Exclusion Recipient Criteria:
1. Not able to understand the information provided during the informed consent procedure
2. Previous solid organ transplantation
3. Grown-up congenital heart disease
4. Dialysis
5. Incompatible blood group
6. Combined organ transplantation candidates
7. Subjects under pre-transplant desensitization protocol (including plasma exchange in conjunction with the transplant surgery)
8. Mechanical circulatory support pre-transplantation (except durable Left ventricular assist device or Intra-aortic balloon pump)
Inclusion - Heart donor
1. Accepted as a heart donor by the transplant team based on current standard of care criteria
2. DCD Maastricht category III and euthanasia donors
3. Age ≤ 60 years old
Exclusion - Heart Donor
1. Functional warm ischemia time (FWIT) \> 30 minutes.
2. Donor cardiac arrest does not occur within 120 minutes from Withdrawal of life sustaining therapy (WLST)
3. Deviations from Donor end of life treatment protocol as defined by local standard operating procedures
4. Donor heart assessed as not transplantable by the responsible clinician at any time point during the donation or procurement procedure
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
